Open AccessSide effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: effect of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC
Author(s) -
Andreas Geier,
Carsten Gartung,
Christoph G. Dietrich,
Hermann E. Wasmuth,
Patrick Reinartz,
Siegfried Matern
Publication year - 2003
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v9.i12.2681
Subject(s) - budesonide , cirrhosis , medicine , gastroenterology , prednisolone , autoimmune hepatitis , hepatocellular carcinoma , hepatitis , alcoholic liver disease , corticosteroid
To investigate the systemic availability of budesonide in a patient with Child A cirrhosis due to autoimmune hepatitis (AIH) and primary hepatocellular carcinoma, who developed serious side effects.